Greece vs Poland: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Greece
89.0%
in 2025
Poland
89.0%
in 2025
Greece rank
72nd
Poland rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Greece
- Poland
How they compare
Greece currently reports 89.0% against 89.0% in Poland, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Poland ahead.
Greece ranks 72nd and Poland ranks 72nd of 194 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 64.0% | 14.9% | 49.1% | Greece |
| 2020s | 92.3% | 88.5% | 3.8% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Greece or Poland?
- Greece, at 89.0% against 89.0% in Poland as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Greece and Poland?
- 0.0%, with Greece ahead.
- How many years of comparable data are there for Greece and Poland?
- 18 years are reported by both, from 2008 to 2025.
- How do Greece and Poland rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Greece ranks 72nd and Poland ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.